Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 669 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Asciminib for Ph+ ALL: a Step Forward
Fabian Lang,Oliver G Ottmann
Bloodno. 6 (2025): 551-552
Cited0Views0WOSBibtex
0
0
Advances and remaining challenges in adult acute lymphoblastic leukaemia
Oliver Ottmann
Medicom Conference Report Proceedings of the 4th European Congress Controversies in Leukemia (2024)
Cited0Views0Bibtex
0
0
Asciminib Monotherapy in Patients with CML-CP Without BCR::ABL1 T315I Mutations Treated with at Least Two Prior TKIs: 4-Year Phase 1 Safety and Efficacy Results
M. Mauro, T. Hughes, Dong-Wook Kim, D. Réa, J. Cortes, A. Hochhaus, K. Sasaki, M. Breccia, M. Talpaz,O. Ottmann, H. Minami, Y. Goh,Daniel J. DeAngelo, M. Heinrich,V. Gómez-García de Soria, P. le Coutre,F. Mahon, J. Janssen, M. Deininger, N. Shanmuganathan, M. Geyer, S. Cacciatore,F. Polydoros,Nithya Agrawal,Matthias Hoch, F. Lang
Leukemia（2023）
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 669

#Citation: 35880

H-Index: 81

G-Index: 179

Sociability: 8

Diversity: 3

Activity: 67

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn